Article

Global Transportability of Clinical Trial Outcomes to Real-World Lung Cancer Populations A case Study using Lung-MAP S1400I

2025-06-01

Abstract excerpt

<h4>Importance</h4> The relevance of randomized clinical trials (RCTs) outcomes to real-world settings – especially across countries – is sometimes limited by their restrictive eligibility criteria and variations in standards of care compared to routine clinical practice. <h4>Objective</h4> To assess the transportability of findings from the RCT Lung-MAP S1400I to real-world populations in the United States (US),...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 76c6c00b-a980-5758-ba37-7bc2f58d6be4
DOI: 10.1101/2025.05.30.25328679

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Global Transportability of Clinical Trial Outcomes to Real-World Lung Cancer Populations A case Study using Lung-MAP S1400IDOI 10.1101/2025.05.30.25328679Read

Transportability of patient outcomes from a US clinical trial to real-world populations - a case study using Lung-MAP S1400I (NCT02785952)Semantic proximity Read

Real-World Data and Evidence in Lung Cancer: A Review of Recent DevelopmentsSemantic proximity Read

External Control Arm with Synthetic Real-world Data for Comparative Oncology using Single Trial Arm Evidence (ECLIPSE): A Case Study using Lung-MAP S1400ISemantic proximity Read

Methodological Challenges using Routine Clinical Care Data for Real-World Evidence: a Rapid Review utilizing a systematic literature search and focus group discussionSemantic proximity Read

The Current Landscape of Clinical TrialsSemantic proximity Read

Leveraging Longitudinal Patient-Reported Outcomes Trajectories to Predict Survival in Non-Small-Cell Lung CancerSemantic proximity Read

The R.O.A.D. to clinical trial emulationSemantic proximity Read

Survival benefit in EGFR-wild and ALK negative NSCLC patients who participate in clinical trials compared to standard-of-care: Propensity-matched analysis.Semantic proximity Read

A Community Challenge to Predict Clinical Outcomes After Immune Checkpoint Blockade in Non-Small Cell Lung CancerSemantic proximity Read

High-Throughput Observational Evidence Generation Using Linked Electronic Health Record and Claims DataSemantic proximity Read

Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation-Positive Lung Cancer in Aotearoa New Zealand: Protocol for a National Whole-of-Patient-Population Retrospective Cohort Study and Results of a Validation Substudy.Semantic proximity Read

Extending Inferences From A Real-world Clinico-Genomic Database Non-Small Cell Lung Cancer Sample To The Underlying Target Population Using Combined Information From Cancer RegistrationsSemantic proximity Read